Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

71.92 -1.86 (-2.52%)
Streaming Delayed Price Updated: 10:25 AM EDT, Sep 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
60 61 Next >
7 Dividend-Paying Healthcare Stocks for Income Investors
With the global markets presenting an ambiguous framework, investors may find confidence in dividend paying healthcare stocks. 
Via InvestorPlace
A Closer Look at CVS Health's Options Market Dynamics
 
Via Benzinga
Secure Your Retirement With These 3 Dividend Stocks
One of the best ways to keep your portfolio safe and generate consistent income is buying reliable dividend stocks. 
Via InvestorPlace
Topics Retirement
Why CVS Health Stock Rallied Wednesday Morning
Wall Street is warming up to the prospects of the healthcare giant. 
Via The Motley Fool
Why CVS Health Jumped Nearly 4% Today
The drugstore chain's 2024 results should be better than most were expecting. 
Via The Motley Fool
CVS Stock Alert: 3 Reasons Why CVS Health Is Up Today
Investors in retail pharmacy chain CVS are cheering today, as CVS stock has surged roughly 4% this afternoon on positive earnings. 
Via InvestorPlace
CVS Corp. (NYSE: CVS) Making Surprising Moves in Tuesday Session
Via Investor Brand Network
7 Analysts Have This to Say About CVS Health
 
Via Benzinga
Nasdaq 100 Forecast: Stocks Slip For A Second Day With Jobs Data In Focus
Stocks are heading for a second day of losses as investors look ahead to data releases ahead of Friday's key non-farm payroll and next week's FOMC meeting. 
Via Talk Markets
Morgan Stanley, CVS Health And More On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners said he is staying with U.S. 
Via Benzinga
Drugstore Chain CVS Health's Move to Simplify Drug Pricing Gives Peek Into FY24 Outlook
CVS Health Corp (NYSE: CVS) announced a new approach called CVS 'CostVantage' that evolves the traditional pharmacy reimbursement model and brings greater transparency and  
Via Benzinga
Opioid Crisis and Corporate Accountability: Purdue's Settlement in the Spotlight
The U.S. Supreme Court is reviewing a contentious bankruptcy settlement involving Purdue Pharma, the maker of OxyContin, and its owners, the Sackler family.  
Via Benzinga
Topics Bankruptcy
Why Realty Income Stock Jumped 14% in November
The real estate industry is improving. 
Via The Motley Fool
Silent Winners: 7 Low-Buzz Stocks With High Potential
With so much of the market chasing heavily hyped ideas, astute investors may want to instead consider hidden-gem stocks. 
Via InvestorPlace
Mega merger in the works? Humana, Cigna explore big deal
Humana and Cigna are exploring a merger, aiming to conclude the deal before year-end, creating a healthcare giant with a potential market value of $137 billion. 
Via MarketBeat
Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio
Faced with a possible negative outcome in the market, these top healthcare stocks should offer the confidence you need. 
Via InvestorPlace
Health Insurance Stocks Cigna (CI), Humana (HUM) Eye Merger
Cigna and Humana are reportedly on the verge of joining forces in an important deal. Here's why this could be bad news for insurance stocks. 
Via InvestorPlace
What's Going On With CVS Stock Today?
CVS Health Corporation (NYSE: CVS) shares are trading lower on Wednesday. 
Via Benzinga
Companies That Grow Through Acquisitions: Pros And Cons
We hit one of dividend growth investors’ favorite business model types: growth through acquisitions. While it often rhymes with dividend growth, there are pros and cons to consider. 
Via Talk Markets
What's Going On With Healthcare Insurance Giant Cigna Stock Today?
Cigna Group (NYSE: CI) and Humana Inc (NYSE: HUM) are reportedly discussing a merger deal to create a new powerhouse in the health insurance industry.  
Via Benzinga
3 No-Brainer Stocks to Buy With $100 Right Now
You don't need a boatload of money to begin building your wealth on Wall Street. 
Via The Motley Fool
Teva Pharma is the way to play the re-rise of generic drugs
Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth 
Via MarketBeat
7 Monthly Dividend Stocks to Buy and Hold for Steady Returns
One of the best ways to protect your portfolio – and generate consistent income – is with these top monthly dividend stocks. 
Via InvestorPlace
5 Telehealth Stocks That Have Nothing But Upside
Dive into the dynamic world of top telehealth stocks. Discover our expert analysis on the gems shaping the future of digital healthcare. 
Via InvestorPlace
Even After a 30,000% Return Over the Last 10 Years, This Stock Could Go Parabolic. Here's Why.
Celsius just completed a 3-for-1 stock split, making now an interesting time to open a position. 
Via The Motley Fool
Buffett, Dalio, Einhorn, Ackman: The Masters Of Wall Street Shuffle Their Stock Decks In Q3
Recent 13F filings unveil the latest investment moves by top hedge funds, revealing shifts in their portfolios and strategic bets in various sectors. 
Via Benzinga
Ray Dalio's Bridgewater Bets Big On Retail With Stakes In Coca-Cola, Costco, And Walmart Among Top Holdings
Ray Dalio's Bridgewater's latest 13F report for Q3 2020 shows 40.63% of his portfolio invested in consumer stocks (discretionary & staples). 
Via Benzinga
3 value stocks you shouldn't let go of this quarter
The market has created the perfect opportunity for you to have your cake and eat it too. These three value stocks will likely be portfolio residents soon 
Via MarketBeat
Topics Bankruptcy
2 Dividend Stocks Near Their 52-Week Lows to Buy and Hold Forever
These longtime healthcare leaders have faced -- and overcome -- plenty of obstacles before. 
Via The Motley Fool
Could Your Eye Drops Be Unsafe? FDA Flags Amazon For Distributing Risky Eye Products, Demands Immediate Action
Amazon.Com, Inc. (NASDAQ: AMZN) has received a  
Via Benzinga
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
60 61 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.